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Dear Editor,
Aggression is a clinical manifestation that usually occurs in 
neurodevelopmental disorders. In intellectual disability, dys-
functional behavior and aggressive and maladaptive responses 
are common. These facts put at risk the patient’s safety and 
cause discomfort in family members and caregivers (Gouveia 
et al., 2019). In general, drug prescription and behavioral therapy 
have favorable results in these individuals. However, there is a 
subset of patients who do not respond adequately to pharmaco-
logical and psychological treatment due to the severity of clin-
ical symptoms and associated brain dysfunction (Torres et al., 
2013) responsible for aggressive behavior. For this limited popu-
lation of individuals, surgical interventions targeting the amyg-
dala or hypothalamus have been proposed.
Deep brain stimulation (DBS) is a promising and novel treat-
ment for a wide group of clinical conditions. Worldwide, the effi-
cacy of posterior hypothalamus DBS for aggressive behavior has 
been significant, but only in several isolated cases (Micieli et al., 
2017). For this reason, we carried out a follow-up study over 
18 months to analyze the effectiveness of DBS at the level of the 
posteromedial hypothalamic nuclei (pHypN) in the aggressive 
behavior of a large cohort of patients with intellectual disability 
refractory to pharmacological and behavioral treatment.
A medical board analyzed the medical records of 19 patients 
who met the inclusion criteria (difficulties with pharmacological 
and psychological treatment for 3  years; professional concept 
of refractoriness to treatment; significant functional impair-
ment objectified by clinical, psychometric, and family report; 
medical control of other disorders and parental consent). 
Before the operative phase, the patients were examined by pro-
fessional experts in neurosurgery, neurology, psychiatry, and 
neuropsychology. We used the Overt Aggression Scale (OAS) 
to quantify behavioral disorders degree (Silver andYudofsky, 
1991). Stereotactic implantation was then performed with the 
Leksell frame under general anaesthesia. It was performed 
using i.v. dexmedetomidine and local nerve block. Contrasting 
stereotactic volumetric images were acquired from computed 
tomography of the brain, which were fused with preoperative 
volumetric brain magnetic resonance imaging with gadolinium, 
with thin axial slices of 1  mm. Surgical planning was carried 
out with the help of Stealth Station Cranial Software (Medtronic, 
Minneapolis, USA) and Inomed software (Emmendingen, 
Germany). The method of Franzini et  al. (2013) and Franzini 
et al. (2005) was used for stereotactic coordinates. Finally, the ag-
gressiveness of patients with OAS was assessed in clinical con-
trols at 6, 12, and 18 months. National and international ethical 
standards were complied with. The study was approved by the 
institutional ethics board (No. 087-2020).
We used repeated-measures ANOVA followed by Bonferroni 
post hoc to analyze the performance of patients in the OAS prior 
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to DBS and in subsequent clinical controls. The effect size of the 
surgical intervention on the performance of the individuals in 
the OAS was then estimated using omega squared and Cohen 
d tests.
The average age of the participants was 18.4 years (SD = 4.00). 
In the neuroimaging study, the finding of cortico-subcortical at-
rophy was generalized. Adverse effects were reported in 1 indi-
vidual due to basal ganglion hemorrhage. At the initial, pre-DBS 
assessment, the patients obtained high scores on the aggres-
siveness scale (ME = 17.73; SD = 2.18). In the post-DBS clinical 
controls at 6 (ME = 9.68; SD = 4.02), 12 (ME = 5.94; SD = 2.27) and 
18 months (ME = 5.1; SD = 1.91), however, these values decreased. 
The repeated-measures ANOVA allowed us to confirm statistic-
ally significant differences in each of the moments in which the 
aggressiveness of the patients with the OAS was evaluated (P < 
.01) next to a high squared omega (ω 2 = 0.789).
On the other hand, the post test of repeated measures 
showed significant intragroup changes in the mean results of 
the OAS before the DBS and the measurements carried out at 6 
(t = 11.27; P < .01), 12 (t = 16.52; P < .01) and 18 months (t = 17.68; 
P < .01), with very large effect sizes (d = 2.58; d = 3.78; d = 4.05), 
respectively. Likewise between the measurement carried out at 
6 months and the clinical controls at 12 (t = 5.23; P < .01) and 
18 months (t = 6.40; P < .01), with sizes of large effect (d = 1.20; 
d  =  1.47). However, between the medical control at 12 and 
18 months, no differences were found in the means of the OAS 
(t = 1.17; P > .05).
DBS at the pHypN level in aggressive behavior refractory to 
pharmacological and behavioral treatment has been used in 
some studies with small samples. In our opinion, this is the 
follow-up study with the largest number of patients reported in 
the medical literature. In our series of cases, a clear reduction in 
aggressive behaviors was achieved and remained constant up 
to 18  months of follow-up (Figure 1), benefiting the quality of 
life and social inclusion of patients. Our data suggest that DBS 
is a successful treatment option for individuals with refractory 
aggression, proving to be effective and safe not only for widely 
known neurological disorders such as Parkinson’s disease, dys-
tonia, obsessive compulsive disorder, and essential tremor 
(Beszłej et al., 2019) but also in neurodevelopmental disorders, 
where the evidence in favor of DBS progresses at a slow pace 
(Ashkan et al., 2020).
We consider that rigorous protocols should be used for the 
selection and inclusion of patients in the clinical procedure and 
more frequent post-surgical controls. It may result in more se-
cure results of the post DBS of pHyp, taking into account that 
some risk factors and complications with DBS may be related 
to the institution where the surgery is performed (Farrokhi 
et al., 2020). In addition, some phenotypic characteristics of the 
clinical conditions of the patients may explain the secondary 
worsening after the application of the technique (Tsuboi et al., 
2020). Finally, we suggest conducting follow-up studies longer 
than 18  months to confirm the time in which aggressive be-
havior stabilizes and flattens (Figure 1).
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